← All sarcoma trials
Recruiting nowN/AAges 18 Years and up

Analysis of Circulating Tumor Markers in Blood

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle · NCT04025541 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

CancerBreast CancerSarcomaLung CancersGliomaColon Cancer

What it tests

  • Blood samplingbiological
  • Blood sampling C3biological
  • Blood sampling C4/7/10/13biological
  • Blood sampling C5biological
  • Blood sampling C6biological
  • Blood sampling C8biological
  • Blood sampling C9biological
  • Blood sampling C11 + FFPEbiological
  • Blood sampling C12biological

Where it's running2 sites

2 international sites
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

1. Patient presenting an invasive tumoral pathology (proved or suspected), whatever is the location or the stage,
2. Man or woman ≥ 18 years,
3. Obtaining of the informed consent signed before any procedure of specific preselection on approval.

Exclusion Criteria:

1. Private persons of freedom or under guardianship,
2. Patient whose regular follow-up is impossible for psychological, family, social or geographical reasons,
3. Pregnant woman and/or breast-feeding,
4. Unaffiliated patient to Social Protection System,

Updated 2025-04-02 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.